Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

Even though a large proportion of cancer patients carry genetic mutations that make them more susceptible to cancer, only a small percentage of them — and their family members — undergo ...

Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients ...

Gram and colleagues describe valid concerns arising from the growing market for medical direct-to-consumer (DTC) tests but do ...

An emerging field of genetics promises to let parents choose the “healthiest” baby.

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris — can help doctors make better decisions ...

Tissue-based genomic classifier tests, developed to improve prostate cancer risk assessment and treatment recommendations, ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa ...